Clinical Care Information for COVID-19
Patients who are moderately or severely immunocompromised or severely allergic to COVID-19 vaccines may be eligible for EVUSHELD™ that can help prevent them from getting COVID-19. For more information about EVUSHELD™, including considerations for variants that may not be neutralized by EVUSHELD™, see FDA’s Fact Sheet for Healthcare Providers.
Guidance by Patient Type
Healthcare providers who have cared or are caring for patients younger than 21 years of age meeting criteria for multisystem inflammatory syndrome in children (MIS-C) should report suspected cases to their local, state, or territorial health department.
For additional reporting questions, please contact CDC’s 24-hour Emergency Operations Center at 770-488-7100.
Names of specific vendors, manufacturers, or products in this collection of content are included for public health and informational purposes; inclusion does not imply endorsement of the vendors, manufacturers, or products by the Centers for Disease Control and Prevention or the US Department of Health and Human Services.